ECHOSENS: FIBROSCAN^®

14/05/2009 : New indication for the FibroScan^®

The HAS (French Health High Authority) enlarges the FibroScan^® indication from the dec 2006 report with a new indication: the co-infection VIH-VHC.
Since 2009 in France, FibroScan^® holds a new place in therapeutic strategy: as a solid evaluation tool for all populations.

• In cases of chronic untreated hepatitis C patients, HAS recommended the FibroScan® in first line and in second line instance as an alternative to liver biopsy (LB).

 

• In the case of VHC-VIH co-infection, HAS recommended only the FibroScan® in first line to evaluate cirrhosis.

 

• The big news is also that the HAS has opened the door to the free blood markers as Hepascore.

sources : "méthodes non invasives de mesure de la fibrose/cirrhose hépatique", dec 2008 HAS